drugset
drugset / Trial / NCT03885778

A Food Effect Study of Besifovir in Healthy Subjects

NCT03885778 ↗

Phase 4 Completed 15 enrolled IlDong Pharmaceutical Co Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the PK characteristics and the effect of food on the PK in healthy volunteers who receive Besifovir dipivoxil in fed versus fasted condition

Timeline

Start
2019-01-13
Primary completion
2019-01-28
Completion
2019-02-12

Drugs

EvaluationDrugModalityDoseRoute
Subject LB80380 Small molecule 150 mg Oral

Indications

No indication recorded.